FORTAZ- ceftazidime injection, powder, for solution
GlaxoSmithKline Manufacturing SpA
----------
NDC 24987-377-10
Fortaz®
(ceftazidime for injection)
500 mg
Equivalent to 500 mg of ceftazidime
For IM or IV use.
Rx only
See prescribing information for Dosage and Administration. Before constitution, store between 15o and 30oC (59o and 86oF) and protect from light.
IMPORTANT: The vial is under reduced pressure. Addition of diluent generates a positive pressure. Before constituting, see Instructions for Constitution. After constitution, solutions maintain potency for 12 hours at room temperature (not exceeding 25oC [77oF]) or for 3 days under refrigeration. Constituted solutions in Sterile Water for Injection may be frozen. See prescribing information for details. Color changes do not affect potency. This vial contains 59 mg of sodium carbonate. The sodium content is approximately 27 mg (1.2 mEq).
Dist. by Covis Pharmaceuticals, Inc.
Made in England
100035
Rev. 5/12
10000000103509
LOT
EXP
10000000103509
NDC 24987-378-10
Fortaz®
(ceftazidime for injection)
1 g
Equivalent to 1 g of ceftazidime
For IM or IV use.
Rx only
See prescribing information for Dosage and Administration. Before constitution, store between 15o and 30oC (59o and 86oF) and protect from light.
IMPORTANT: The vial is under reduced pressure. Addition of diluent generates a positive pressure. Before constituting, see Instructions for Constitution. After constitution, solutions maintain potency for 12 hours at room temperature (not exceeding 25oC [77oF]) or for 3 days under refrigeration. Constituted solutions in Sterile Water for Injection may be frozen. See prescribing information for details. Color changes do not affect potency. This vial contains 118 mg of sodium carbonate. The sodium content is approximately 54 mg (2.3 mEq).
Dist. by Covis Pharmaceuticals, Inc.
Made in England
Rev. 5/12
100037
10000000103726
LOT
EXP
10000000103726
NDC 24987-379-34
Fortaz®
(ceftazidime for injection)
2 g
Equivalent to 2 g of ceftazidime
For IV use.
Rx only
See prescribing information for Dosage and Administration. Before constitution, store between 15o and 30oC (59o and 86oF) and protect from light.
IMPORTANT: The vial is under reduced pressure. Addition of diluent generates a positive pressure. Before constituting, see Instructions for Constitution. To prepare IV solution, add 10 mL of Sterile Water for Injection. After constitution, solutions maintain potency for 12 hours at room temperature (not exceeding 25oC [77oF]) or for 3 days under refrigeration. Constituted solutions in Sterile Water for Injection may be frozen. See prescribing information for details. Color changes do not affect potency. This vial contains 236 mg of sodium carbonate. The sodium content is approximately 108 mg (4.7 mEq).
Dist. by Covis Pharmaceuticals, Inc.
Made in England
100031
Rev. 5/12
10000000103587
LOT
EXP
10000000103587
NDC 24987-382-37
Fortaz®
(ceftazidime for injection)
6 g
Equivalent to 6 g of ceftazidime
Pharmacy Bulk Package
Rx only
See package insert for Dosage and Administration. Before constitution, store between 15o and 30oC (59o and 86oF) and protect from light.
IMPORTANT: The vial is under reduced pressure. Addition of diluent generates a positive pressure. Before constituting, see Instructions for Constitution.
To prepare solution, add 26 mL of Sterile Water for Injection. Shake well to dissolve. The constituted solution occupies a volume of about 31.5 mL and contains approximately 1 g of ceftazidime activity per 5 mL.
After constitution, solutions maintain potency for 12 hours at room temperature (not exceeding 25oC [77oF]) or for 3 days under refrigeration. Color changes do not affect potency. This vial contains 709 mg of sodium carbonate. The sodium content is approximately 54 mg (2.3 mEq) per gram of ceftazidime.
Dist. by Covis Pharmaceuticals, Inc.
Cary, NC 27511
Made in England
10000000103768
100039
Rev. 5/12
LOT
EXP
NDC 24987-434-00
Fortaz®
(ceftazidime for injection)
TwistVialTM
1 g
Equivalent to 1 g of ceftazidime
For IV use.
Rx only
See prescribing information for Dosage and Administration and Instructions for Constitution.
Before constitution, store between 15o and 30oC (59o and 86oF) and protect from light.
Color changes do not affect potency. This vial contains 118 mg of sodium carbonate. The sodium content is approximately 54 mg (2.3 mEq).
Distributed by:
Covis Pharmaceuticals, Inc.
Cary, NC 27511
Made in England
Rev. 4/12
100001
10000000103171
LOT
EXP
NDC 54987-435-00
Fortaz®
(ceftazidime for injection)
TwistVialTM
2 g
Equivalent to 2 g of ceftazidime
For IV use.
Rx only
See prescribing information for Dosage and Administration and Instructions for Constitution.
Before constitution, store between 15o and 30oC (59o and 86oF) and protect from light.
Color changes do not affect potency. This vial contains 236 mg of sodium carbonate. The sodium content is approximately 108 mg (4.7 mEq).
Distributed by:
Covis Pharmaceuticals, Inc.
Cary, NC 27511
Made in England
Rev. 4/12
100004
10000000103176
LOT
EXP
FORTAZ
ceftazidime injection, powder, for solution |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
FORTAZ
ceftazidime injection, powder, for solution |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
FORTAZ
ceftazidime injection, powder, for solution |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
FORTAZ
ceftazidime injection, powder, for solution |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
FORTAZ
ceftazidime injection, powder, for solution |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
FORTAZ
ceftazidime injection, powder, for solution |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - GlaxoSmithKline Manufacturing SpA (338773877) |